These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
693 related articles for article (PubMed ID: 7478595)
1. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. Johnson DG Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595 [TBL] [Abstract][Full Text] [Related]
2. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions. Oswald F; Lovec H; Möröy T; Lipp M Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548 [TBL] [Abstract][Full Text] [Related]
3. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1. Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707 [TBL] [Abstract][Full Text] [Related]
4. Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth. Smith EJ; Leone G; Nevins JR Cell Growth Differ; 1998 Apr; 9(4):297-303. PubMed ID: 9563849 [TBL] [Abstract][Full Text] [Related]
5. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation. Kiess M; Gill RM; Hamel PA Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter. Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003 [TBL] [Abstract][Full Text] [Related]
7. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350 [TBL] [Abstract][Full Text] [Related]
8. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression. Hiyama H; Iavarone A; LaBaer J; Reeves SA Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes. Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422 [TBL] [Abstract][Full Text] [Related]
11. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter. Araki K; Nakajima Y; Eto K; Ikeda MA Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826 [TBL] [Abstract][Full Text] [Related]
12. Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells. Sala A; Nicolaides NC; Engelhard A; Bellon T; Lawe DC; Arnold A; Graña X; Giordano A; Calabretta B Cancer Res; 1994 Mar; 54(6):1402-6. PubMed ID: 8137237 [TBL] [Abstract][Full Text] [Related]
13. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells. Zhu WY; Jones CS; Kiss A; Matsukuma K; Amin S; De Luca LM Exp Cell Res; 1997 Aug; 234(2):293-9. PubMed ID: 9260897 [TBL] [Abstract][Full Text] [Related]
14. The role of p16 in the E2F-dependent thymidine kinase regulation. Hengstschläger M; Hengstschläger-Ottnad E; Pusch O; Wawra E Oncogene; 1996 Apr; 12(8):1635-43. PubMed ID: 8622883 [TBL] [Abstract][Full Text] [Related]
15. Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop. Howard CM; Claudio PP; De Luca A; Stiegler P; Jori FP; Safdar NM; Caputi M; Khalili K; Giordano A Cancer Res; 2000 May; 60(10):2737-44. PubMed ID: 10825149 [TBL] [Abstract][Full Text] [Related]
16. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells. Gill RM; Slack R; Kiess M; Hamel PA Exp Cell Res; 1998 Oct; 244(1):157-70. PubMed ID: 9770359 [TBL] [Abstract][Full Text] [Related]
17. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters. O'Connor RJ; Schaley JE; Feeney G; Hearing P Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936 [TBL] [Abstract][Full Text] [Related]
18. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. Hiyama H; Iavarone A; Reeves SA Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018 [TBL] [Abstract][Full Text] [Related]
19. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts. Bennett JD; Farlie PG; Watson RJ Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697 [TBL] [Abstract][Full Text] [Related]
20. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering. Alesse E; Zazzeroni F; Angelucci A; Giannini G; Di Marcotullio L; Gulino A Cell Death Differ; 1998 May; 5(5):381-9. PubMed ID: 10200487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]